学术探索
学术期刊
新闻热点
数据分析
智能评审

Peroxisome proliferator-activated receptor α/γ dual Agonists for the treatment of type 2 diabetes

被引：130
作者：
Henke, BR [1 ]
机构：
[1] GlaxoSmithKline, Metab & Viral Dis Drug Discovery Res, Res Triangle Pk, NC 27709 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2004年 / 47卷 / 17期
关键词：
D O I：
10.1021/jm030631e
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：4118 / 4127
页数：10
相关论文
共 63 条
  • [41] (-)3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: A dual PPAR agonist with potent antihyperglycemic and lipid modulating activity
    Lohray, BB
    Lohray, VB
    Bajji, AC
    Kalchar, S
    Poondra, RR
    Padakanti, S
    Chakrabarti, R
    Vikramadithyan, RK
    Misra, P
    Juluri, S
    Mamidi, NVSR
    Rajagopalan, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (16) : 2675 - 2678
  • [42] THE RXR HETERODIMERS AND ORPHAN RECEPTORS
    MANGELSDORF, DJ
    EVANS, RM
    [J]. CELL, 1995, 83 (06) : 841 - 850
  • [43] Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency
    Miles, PDG
    Barak, Y
    He, WM
    Evans, RM
    Olefsky, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (03) : 287 - 292
  • [44] Novel peroxisome proliferator-activated receptor ligands for Type 2 diabetes and the metabolic syndrome
    Miller, AR
    Etgen, GJ
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (09) : 1489 - 1500
  • [45] New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers
    Mudaliar, S
    Henry, RR
    [J]. ANNUAL REVIEW OF MEDICINE, 2001, 52 : 239 - 257
  • [46] MUDALIAR S, 2002, CURR OPIN ENDOCRINOL, V9, P285
  • [47] A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-α.: (PPAR-α) and PPAR-γ -: Effect of PPAR-α activation on abnormal lipid metabolism in liver of Zucker fatty rats
    Murakami, K
    Tobe, K
    Ide, T
    Mochizuki, T
    Ohashi, M
    Akanuma, Y
    Yazaki, Y
    Kadowaki, T
    [J]. DIABETES, 1998, 47 (12) : 1841 - 1847
  • [48] Lipid-lowering drugs: Are adverse effects predictable and reversible?
    Muscari, A
    Puddu, GM
    Puddu, P
    [J]. CARDIOLOGY, 2002, 97 (03) : 115 - 121
  • [49] (3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents
    Nomura, M
    Kinoshita, S
    Satoh, H
    Maeda, T
    Murakami, K
    Tsunoda, M
    Miyachi, H
    Awano, K
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (04) : 533 - 538
  • [50] Peroxisome proliferator activated receptor-α expression in human liver
    Palmer, CNA
    Hsu, MH
    Griffin, KJ
    Raucy, JL
    Johnson, EF
    [J]. MOLECULAR PHARMACOLOGY, 1998, 53 (01) : 14 - 22
1234567